‘Poorly designed’: Indian Council of Medical Research (ICMR) distance itself from BHU study on Covaxin | Delhi News – Times of India
NEW DELHI: Researchers from Banaras Hindu University (BHU) have conducted a one-year follow-up study on individuals who received Bharat Biotech’s Covaxin. The study revealed that approximately one-third of the participants experienced ‘adverse events of special interest’ (AESI) after receiving the vaccine. Dr Rajiv Bahl, the director general of ICMR, has responded to the study by…